Mexiletine in the treatment of resistant ventricular arrhythmias: enhancement of efficacy and reduction of dose-related side effects by combination with quinidine.
D001145:Arrhythmias, Cardiac / Q000188:drug therapy* / Q000503:physiopathology; D003327:Coronary Disease / Q000188:drug therapy / Q000503:physiopathology; D003967:Diarrhea / Q000139:chemically induced; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D004562:Electrocardiography; D004594:Electrophysiology; D006352:Heart Ventricles; D006801:Humans; D008801:Mexiletine / Q000008:administration & dosage* / Q000009:adverse effects; D010349:Patient Compliance; D011437:Propylamines / Q000008:administration & dosage*; D011802:Quinidine / Q000008:administration & dosage* / Q000009:adverse effects; D013610:Tachycardia / Q000188:drug therapy / Q000503:physiopathology; D014693:Ventricular Fibrillation / Q000188:drug therapy / Q000503:physiopathology
D011437:Propylamines; D008801:Mexiletine; D011802:Quinidine